Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medicine Manufacturing	3.11B	2.93B	2.69B	2.33B	1.63B
Medicine Manufacturing Growth	6.15%	8.85%	15.75%	42.92%	66.40%
Total	3.11B	2.93B	2.69B	2.33B	1.63B
Total Growth	6.15%	8.85%	15.75%	42.92%	66.40%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
North-East China	108.27M	87.28M	124.19M	84.25M	64.47M
North-East China Growth	24.04%	-29.72%	47.40%	30.69%	22.50%
North China	327.58M	282.25M	402.36M	458.60M	287.08M
North China Growth	16.06%	-29.85%	-12.26%	59.75%	93.67%
East China	1.12B	1.15B	903.60M	794.42M	589.81M
East China Growth	-2.56%	26.77%	13.74%	34.69%	63.90%
South China	392.54M	339.99M	292.57M	244.32M	186.25M
South China Growth	15.46%	16.21%	19.75%	31.18%	45.95%
Central China	542.78M	497.31M	418.56M	359.77M	249.27M
Central China Growth	9.14%	18.81%	16.34%	44.33%	89.62%
North-West China	184.45M	158.38M	150.34M	106.95M	76.63M
North-West China Growth	16.46%	5.35%	40.57%	39.58%	102.61%
South-West China	375.30M	364.04M	351.82M	234.01M	146.86M
South-West China Growth	3.09%	3.47%	50.34%	59.34%	60.63%
Export	60.96M	54.75M	48.05M	-	-
Export Growth	11.35%	13.94%	-	-	-
Unallocated	2.79M	1.15M	1.02M	893.62K	818.09K
Unallocated Growth	143.24%	12.34%	14.17%	9.23%	-66.61%
Foreign	-	-	-	43.00M	26.47M
Foreign Growth	-	-	-	62.42%	-0.74%
Total	3.11B	2.93B	2.69B	2.33B	1.63B
Total Growth	6.15%	8.85%	15.75%	42.92%	66.40%

Source: S&P Global Market Intelligence.